AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
This chapter investigates how SGL2 inhibitors impact hemoglobin levels in heart failure patients, citing a case study where a patient's hemoglobin increased post-guideline-directed therapy. The discussion examines the mechanism of SGL2 inhibitors and their broader benefits, shedding light on the implications for hematology.